ホームMCPワークベンチSkills
ホームワークベンチ通知マイページ
llms.txt · MCPガイドプライバシーポリシー · 利用規約 · サポートv1.8.3
  1. ホーム
  2. /化合物

(R)-アルブテロール塩酸塩

Levalbuterol Hydrochloride

HCID 123601
反応を作成
印刷
基本情報概要名称と識別子物性安全と法規制化学と産業関連反応化合物ノート
部分構造検索類似構造を探す

基本情報

CAS
50293-90-8
標準SMILES
CC(C)(C)NC[C@H](O)c1ccc(O)c(CO)c1.Cl
InChIKey
OWNWYCOLFIFTLK-YDALLXLXSA-N
分子式
C13H22ClNO3
平均分子量
275.77 g/mol
単同位体質量
275.12882124

概要

Levalbuterol Hydrochloride is the hydrochloride salt form of levalbuterol, a relatively selective sympathomimetic beta-2 adrenergic receptor agonist with bronchodilator activity. Levalbuterol hydrochloride binds to beta-2 adrenergic receptors in bronchial smooth muscle and activates intracellular adenyl cyclase, thereby increasing the production of cyclic-3', 5'-adenosine monophosphate (cAMP). Increased cAMP levels lead to the activation of protein kinase A, which inhibits the phosphorylation of myosin and lowers intracellular ionic calcium concentrations, resulting in relaxation of bronchial smooth muscles. The increased cyclic AMP concentrations also inhibit the release of inflammatory mediators from mast cells.

名称と識別子

優先名称
Levalbuterol Hydrochloride
IUPAC
4-[(1R)-2-(tert-butylamino)-1-hydroxyethyl]-2-(hydroxymethyl)phenol;hydrochloride
現地名
(R)-アルブテロール塩酸塩
英語名
alfa1-[[1,1-Dimethylethylamino]methyl]-4-hydroxy-1-(S),3-benzene dimethanol Hydrochlorid
分子式
C13H22ClNO3
分子量
275.77168

名称と別名

Levalbuterol hydrochloride50293-90-8Levalbuterol HClXopenexLevosalbutamol Hydrochloride(-)-Salbutamol hydrochlorideAlbuterol hydrochloride, r-WDQ1526QJMNSC-759255Albuterol (r)-form hydrochlorideDTXSID20198296RefChem:56699
名称をさらに表示
(R)-アルブテロール塩酸塩レバルブテロール塩酸塩レバルブテロール 塩酸塩塩酸レバルブテロールZopenexUnii-wdq1526qjmSalbutamol HydrochlorideSalbutamol (R)-Isomer HClSalbutamol Impurity 8 HClSalbutamol Impurity 14 HCl
Levalbuterol Inhalation SolutionDTXCID501207871,3-Benzenedimethanol, alpha1-(((1,1-dimethylethyl)amino)methyl)-4-hydroxy-, Hydrochloride,(alpha1R)-(R)-Albuterol Hydrochloride(R)-Salbutamol hydrochlorideSalbutamol (hydrochloride)R-albuterol hydrochloride(R)-4-(2-(tert-Butylamino)-1-hydroxyethyl)-2-(hydroxymethyl)phenol hydrochloride

データベース識別子

CAS

物性

構造計算による物性

極性表面積
72.7 Ų
水素結合供与体数
5
水素結合受容体数
4
回転可能結合数
5
重原子数
18
形式電荷
0
複雑度
227

実験および物理化学的性質

Human Drugs · 2 件

FDA approved drugs -> Active ingredient

FDA approved drugs -> Active ingredient

Collision Cross Section158.1 Ų [M+H]+ [CCS Type: TW; Method: calibrated with polyalanine and drug standards]

物理化学的性質

融点
169 · 169-171°C
比旋光度
20 · D20 -32.2° (c = 0.1 in water)
貯蔵温度
2 · 2-8°C
溶解性
2 O: · H2O: ≥15mg/mL
外見
粉
色
白から黄褐色
水溶解度
2 O: · H2O: ≥15mg/mL
InChI
InChI=1/C13H21NO3.ClH/c1-13(2,3)14-7-12(17)9-4-5-11(16)10(6-9)8-15;/h4-6,12,14-17H,7-8H2,1-3H3;1H/t12-;/s3
InChIKey
OWNWYCOLFIFTLK-ZLBVLXFENA-N
SMILES
c1(CO)cc([C@@H](O)CNC(C)(C)C)ccc1O.Cl |&1:5,r|

化学的性質

化学的特性Off-White Solid

安全と法規制

安全情報は参考情報です。供給元の安全データシート(SDS)、適用法令、専門家による評価に代わるものではありません。

GHS分類

GHS Classification · 4 件

Danger

H302 (100%): Harmful if swallowed [Warning Acute toxicity, oral]

P261, P264, P264+P265, P270, P271, P280, P301+P317, P302+P352, P304+P340, P305+P354+P338, P317, P319, P321, P330, P332+P317, P362+P364, P403+P233, P405, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 43 reports by companies from 6 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.

危険有害性情報

Hazard Classes and CategoriesAcute Tox. 4 (100%)

毒性情報

Exposure RoutesSystemic absorption is rapid following aerosol administration.
Toxicity Summary · 1 件

Salbutamol is a beta(2)-adrenergic agonist and thus it stimulates beta(2)-adrenergic receptors. Binding of albuterol to beta(2)-receptors in the lungs results in relaxation of bronchial smooth muscles. It is believed that salbutamol increases cAMP production by activating adenylate cyclase, and the actions of salbutamol are mediated by cAMP. Increased intracellular cyclic AMP increases the activity of cAMP-dependent protein kinase A, which inhibits the phosphorylation of myosin and lowers intracellular calcium concentrations. A lowered intracellular calcium concentration leads to a smooth muscle relaxation and bronchodilation. In addition to bronchodilation, salbutamol inhibits the release of bronchoconstricting agents from mast cells, inhibits microvascular leakage, and enhances mucociliary clearance.

Carcinogen ClassificationNo indication of carcinogenicity to humans (not listed by IARC).
Toxicity DataLD<sub>50</sub>=1100 mg/kg (orally in mice)

化学と産業

薬理情報

Metabolism/Metabolites · 1 件

Hydrolyzed by esterases in tissue and blood to the active compound colterol. The drug is also conjugatively metabolized to salbutamol 4'-O-sulfate. Route of Elimination: Approximately 72% of the inhaled dose is excreted in the urine within 24 hours, 28% as unchanged drug and 44% as metabolite. Half Life: 1.6 hours

FDA Pharmacological Classification · 4 件

LEVALBUTEROL HYDROCHLORIDE

beta2-Adrenergic Agonist [EPC]; Adrenergic beta2-Agonists [MoA]

LEVALBUTEROL INHALATION SOLUTION

Adrenergic beta2-Agonists [MoA]; beta2-Adrenergic Agonist [EPC]

用途と製造

UsesFor symptomatic relief and prevention of bronchospasm due to bronchial asthma, chronic bronchitis, and other chronic bronchopulmonary disorders such as COPD.
応用分野 · 2 件

説明Salbutamol is an agonist of the β2-adrenergic receptor (β2-AR; Kd = 759 nM in a radioligand binding assay using CHO cells expressing the human receptor). It is selective for β2-ARs over β1- and β3-ARs (Kds = 46.8 and 21.9 μM, respectively). Salbutamol (25-50 μg/kg, i.v.) reduces acetylcholine-induced bronchospasm in anesthetized guinea pigs. It also reduces response of bronchial muscle to efferent vagal stimulation in anesthetized cats and dogs when administered at doses ranging from 1 to 2.5 and 10 to 20 μg/kg, respectively. Nebulized salbutamol reduces transpulmonary pressure in recurrent airway obstruction-affected horses (EC50 = 39.7 μg). Formulations containing salbutamol have been used in the treatment of asthma and chronic obstructive pulmonary disease (COPD).

使用The R-enantiomer

上流・下流製品情報

上流原料

tert-ブチルアミン

関連反応

4 件
反応記録を作成
HRID 1078016 の反応式
HRID 1078016生成物として
HRID 1455721 の反応式
HRID 1455721生成物として反応物として
HRID 2375770 の反応式
HRID 2375770反応物として
HRID 2375771 の反応式
HRID 2375771反応物として

化合物ノート

このページの内容基本情報概要名称と識別子物性安全と法規制化学と産業関連反応化合物ノート
50293-90-8
PubChem CID
123601
DTXSID
DTXSID20198296
ChEMBL
CHEMBL1201061
UNII
WDQ1526QJM
EC Number
627-135-3

安全データ

wgk
3
hs_code
2922504500
risk_code
22-37/38-41
hazard_code
Xn
safety_code
26-39
Hazard Classifications
Acute Tox. 4 OralEye Dam. 1Skin Irrit. 2STOT SE 3
ストレージクラス
11 - Combustible Solids
臭化水素酸
5-アセチルサリチル酸メチル
ジメチル スルフィド ボラン
水酸化パラジウム / 炭素